MFY.F Mochida Pharmaceutical Co. Ltd

Healthcare Pharmaceuticals Frankfurt Exchange
18.60 EUR
Close of Nov 12, 2026
16.08 21.26
Market cap
EUR 653M
P/E
11.2x
P/B
0.80x
ROE
9.4%
Dividend yield
2.65%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.

Is MFY.F undervalued?

Graham number
Price18.60
Graham value29.54
Discount37.0%

MFY.F trades 37.0% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Mochida Pharmaceutical Co. Ltd fundamental analysis

No fundamental analysis for Mochida Pharmaceutical Co. Ltd yet.

Mochida Pharmaceutical Co. Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Mochida Pharmaceutical Co. Ltd

Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan. The company offers pharmaceuticals products for the treatment of cardiovascular, obstetrics, gynecology, dermatologists, psychiatry, and gastroenterological, including Realda and Collagen for the treatment of ulcerative colitis; Goofis and Movicol for the treatment of chronic constipation; interstitial pulmonary hypertension for the treatment of pulmonary arterial hypert…

Full company profile